General Considerations

Methods:
Stainless steel syringes were used to transfer air-and moisture-sensitive liquids. Reactions were monitored by thinlayer chromatography (TLC) on Silica Gel 60 F254 plates (EMD) under UV light (254 nm) or visualized with KMnO4 upon heating. Flash chromatography was performed using Silica Gel 60 (230-400 mesh, EM Science), SiliaFlash P60 (230-400 mesh, SiliCycle), or 200-400 mesh silica gel (Sorbent Technologies). Organic solutions were concentrated under reduced pressure on a Büchi or Heidolph rotary evaporator. Analytical thin-layer chromatography (TLC) was accomplished with UV light (254 nm), and column chromatography was mediated on a Biotage Isolera flash chromatography system using SNAP KP-Sil or Ultra-Sil columns (silica gel, average particle size 50 µM).
Continuous flow equipment was assembled from commercially available components supplied from IDEX Health & Science Technologies, and backpressure regulators were purchased from Zaiput Flow Technologies. Reactors were constructed from high-purity perfluoroalkoxy (PFA) tubing with a 1/16" outside diameter and either 0.02″ or 0.04″ inside diameter as well as stainless steel (SS) tubing with a 1/16" outside diameter and 0.04″ inside diameter, with complementary PEEK fittings. Harvard Apparatus PhD Ultra syringe pumps were used to infuse solutions contained within 8 mL high-pressure stainless steel syringes with 1/16" SWAGELOCK ® fitting. The check valves used had a CV inlet 1/4-28 (Perfluor), T-mixers were IDEX Tee Assy 1/8" PEEK 0.050 through, and ferrules were SF, SS Ring, 1/16", TZ.
Materials and reagents:
Commercial reagents were purchased from Millipore Sigma, Alfa Aesar, Strem, Oakwood Chemical, Acros
Organics, Fisher Scientific, Matrix Scientific, or TCI and used without purification unless otherwise indicated.
Methyl-4-methoxyacetoacetate (97%) was distilled prior to use in the first step of the flow synthesis. Sodium methoxide solution in methanol was purchased from Alfa Aesar and used as received. Where specified, CH3CN, CH2Cl2, toluene, THF, and 1,4-dioxane (PURE SOLV) were dried by passing through columns of activated alumina.
Deuterated solvents CDCl3, CD3OD, and DMSO-d6 (Cambridge Isotope Laboratories or Millipore Sigma) were used without purification. Extraction and chromatography solvents were reagent grade and used without purification (VWR, Fisher Scientific or Millipore Sigma). Molecular sieves (4Å) were activated by heating in vacuo and stored in a vial in a dessicator. HPLC solvents were used without purification (VWR, Fisher Scientific).
Instrumentation:
Proton nuclear magnetic resonance ( 1 H NMR) spectra and proton-decoupled carbon nuclear magnetic resonance 12 (50 mL, 1 equiv) and Vapourtec Pump B was used to pump the neat stock of dimethyl formamide dimethylacetal (DMF-DMA) 13 (60 ml, 1.6 equiv). Solutions A and B were mixed at a T-piece (M1) (IDEX Health and Science, P-726 used with blanking plugs) and pumped through Reactor I. A 40 psi back pressure regulator (BPR) (IDEX Health and Science, P-785) was connected after Reactor I (Step 1). The output from Reactor I was connected to a second T-piece (M2) with an incoming neat solution of aminoacetaldehyde dimethylacetal (AADMA) 15 (60 ml, 1 equiv) that was pumped using a Syrris ASIA Pump C. The collective flow stream was allowed to pump into Reactor II. A 100 psi back pressure regulator (BPR) (IDEX Health and Science, P-787) was connected after Reactor II. After approximately three total system residence times, the output flow from Reactor II was collected for 15 mins (19.8 mL, 32.9 mmol of rate limiting material). The reactant mixture was concentrated in vacuo and purified using flash chromatography (50-100% EtOAc/hexanes) to give pure 6 (7.16 g, 27.4 mmol, 95%). 196.9, 166.9, 160.9, 102.8, 98.5, 76.5, 59.1, 54.8, 51 .9, 50.8. (IDEX, P-785) was connected after the reactor. After approximately three total system residence times, the output flow from the reactor was collected for 60 mins (19.8 mL, 7.2 mmol of rate limiting material). The reactant mixture was concentrated in vacuo and the residue was then dissolved in 1 M citric acid solution. The aqueous phase was extracted with CH2Cl2 (3 x 15 mL) and the combined organic phase dried over anhydrous sodium sulfate. The solution was filtered under gravity and the filtrate was evaporated to dryness under reduced pressure on a rotary evaporator to afford pure 16 (2.2 g, 6.68 mmol, 91%). 
Dimethyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate 16:
The three-step telescoped sequence was conducted in a continuous flow system without isolation of any intermediates or the inline separation of any co-products, byproducts, or excess reagents. Methyl-4-methoxyacetoacetate 12 (10 mL, 1 equiv) and N,N-dimethylformamide dimethyl acetal 13 (10 mL, 1.5 equiv) were streamed neat at 40 µL/min and 60 µL/min, respectively, via a Chemyx Nexus 3000 infuse/withdraw syringe pump and pumped into a 1 mL ETFE tube reactor (0.02" I.D.) at 85 °C with a residence time of 10 min. The reactor outcome was streamed into a Tpiece with aminoacetaldehyde dimethyl acetal 15 (10 mL, 1.5 equiv) at 50 µL/min (Chemyx Nexus 3000) and pumped into Reactor II, a 1 mL ETFE tube reactor (0.02" I.D.) for 6.7 min of residence time at 70 °C. The combined reactor outcome was streamed into a T-piece with a solution of preheated dimethyl oxalate 7 (20.0 g, 3.0 equiv, 2 M) in methanol at 40 °C at 0.46 mL/min (Eldex Optos series high pressure liquid metering pump) and pumped into Reactor III, a 1 mL ETFE tube reactor (0.04" I.D.) at 25 °C with a residence time of 1.6 min. The combined reactor outcome was then streamed into a T-piece with NaOMe 25% w/w in MeOH (20 mL, 1.5 equiv) at 0.10 mL/min (Eldex Optos series) into Reactor IV, a 39 mL ETFE tube reactor (0.04" I.D.) at 85 °C with a residence time of 55 min to yield an orange solution. At a total flow rate of 0.71 mL/min, the crude reaction mixture was collected for 25 mins. The reactant mixture was concentrated in vacuo and the residue was then dissolved in 11 mL of 1 M citric acid solution. The aqueous phase was extracted with CH2Cl2 (3 x 15 mL) and the combined organic phase dried over anhydrous sodium sulfate. The reactant mixture was concentrated in vacuo and purified using flash chromatography (50-100% EtOAc/hexanes) to give pure 16 (1.4 g, 4.25 mmol, 56%). 165.8, 162.7, 150.7, 146.3, 133.9, 118.6, 103.0, 60.8, 56.9, 56.0, 53.6, 52 .6.
Methyl 5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-
carboxylate 17: Flow setup was assembled with a 0.05" thru T-mixer (1/8" PEEK) at the entry to the reactor which consisted of stainless steel tubing 1/16" x 0.04" x 25'. Two solutions were prepared in 10 mL vials, and 7 mL of the resulting solutions were loaded into dry stainless steel Harvard syringes. Zaiput BPR was set at 100 psi, with the output directly going into a vial.
Solution 1:
Ester 16 (1.05 g, 3.2 mmol, 1.0 equiv) and AcOH (0.91 mL, 15.9 mmol, 5 equiv) were dissolved with PhCH3 to afford a 7 mL solution.
Solution 2: Difluorobenzylamine 9 (0.46 mL, 3.8 mmol, 1.2 equiv) was dissolved with PhCH3 to afford a 7 mL solution.
Harvard syringe pumps were set to infuse at 25 µL min -1 (total flow rate = 50 µL min -1 ), and the solution collected at the outlet of the continuous flow system for an equilibration period of 360 min. At this time, the reactant mixture was collected for 60 min (3.0 mL, 0.69 mmol of rate limiting material) into a vial; when 8 mL stainless steel syringes were empty, the syringes were recharged with 6 mL of dry PhCH3 as a carrier solvent. The reactant mixture was concentrated in vacuo and purified using flash chromatography (10-80% EtOAc/hexanes) to give pure 17 (290 mg, 0.66 mmol, 96% yield). connected to a T-mixer into PFA tubing 1/16" x 0.04" x 10'. Two solutions were prepared in 10 mL vials, and 6 mL of the resulting solutions were loaded into dry stainless steel Harvard syringes.
Ester 16 (1.07 g, 3.2 mmol, 1.0 equiv) and AcOH (0.92 mL, 15.9 mmol, 5 equiv) were dissolved with PhCH3 to afford a 8 mL solution.
Solution 2: Difluorobenzylamine 9 (0.46 mL, 3.8 mmol, 1.2 equiv) was dissolved with PhCH3 to afford a 8 mL solution.
Solution 3: p-Toluenesulfonic acid monohydrate (615 mg, 3.2 mmol, 1.0 equiv) was dissolved with CH3CN to afford a 6 mL solution.
Solution 4: (R)-3-Aminobutan-1-ol 18 (0.47 mL, 4.9 mmol, 1.5 equiv) was dissolved with CH3CN to afford a 6 mL solution.
Harvard syringe pump with solutions 1 and 2 was set to infuse at 25 µL min -1 (total flow rate in 1st reactor = 50 µL min -1 ), Harvard syringe pump with solutions 3 and 4 was set to infuse at 20 µL min -1 (total flow rate in 2nd reactor = 70 µL min -1 , total flow rate in 3rd reactor = 90 µL min -1 ) and the solution collected at the outlet of the continuous flow system for an equilibration period of 540 min. At this time, the reactant mixture was collected for 60 min (5.4 mL, 0.62 mmol of rate limiting material) into a vial with sat. NaHCO3; when 8 mL stainless steel syringes were empty, the syringes were recharged with 6 mL of dry PhCH3 as a carrier solvent and pumping was resumed. The aqueous layer was extracted with EtOAc and the reactant mixture was concentrated in vacuo and purified using flash chromatography (20-100% EtOAc/hexanes) to give pure 19 (131 mg, 0.32 mmol, 48% yield). Diastereomeric ratio was calculated by integrating the crude 1 H NMR spectrum as well as HPLC analysis using ChiralPak AD-H column, which both gave a 7:1 ratio. 142.4, 131.1, 129.5, 119.4, 111.7, 104.2, 76.5, 62.9, 61.6, 54.0, 45.0, 37.0, 29.8, 16 .5. 9, 170.8, 163.6, 162.1, 161.1, 159.5, 154.1, 153.8, 137.6, 130.7, 128.8, 121.1, 114.4, 111.4, 104.1, 61.0, 47.8, 36.8, 33.6, 20.9, 19 Solution 2: LiBr (220 mg, 2.54 mmol, 2.2 equiv) was dissolved with THF to afford a 8 mL solution.
HR-MS
Harvard syringe pump was set to infuse at 20 µL min -1 (total flow rate in 1st reactor = 40 µL min 164.3, 163.3, 162.6, 161.8 (dd, J = 249, 12 Hz), 156.1, 140.3, 130.3, 121.7, 116.6, 115.9, 111.3, 103.8, 76.4, 62.8, 52.5, 44.8, 36.6, 29.4, 15.6 . 
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